Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7721804rdf:typepubmed:Citationlld:pubmed
pubmed-article:7721804lifeskim:mentionsumls-concept:C1882687lld:lifeskim
pubmed-article:7721804lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:7721804lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:7721804lifeskim:mentionsumls-concept:C0085966lld:lifeskim
pubmed-article:7721804pubmed:issue15lld:pubmed
pubmed-article:7721804pubmed:dateCreated1995-5-19lld:pubmed
pubmed-article:7721804pubmed:abstractTextThe expression pattern of mitochondrial carnitine palmitoyltransferase (CPT) enzymes was examined in the developing rat heart. Whereas the specific activity of CPT II increased approximately 3-fold during the first month of life, the profile for CPT I, which is composed of both liver (L) and muscle (M) isoforms, was more complex. Exposure of mitochondria to [3H]etomoxir (a covalent ligand for CPT I), followed by fluorographic analysis of the membrane proteins, established that while in the adult heart L-CPT I represents a very minor constituent, its contribution is much greater in the newborn animal. Use of the related inhibitor, 2-[6-(2,4-dinitrophenoxy)hexyl]oxirane-2-carboxylic acid (specific for L-CPT I), allowed the activities of the two CPT I variants to be quantified separately. The results showed that in the neonatal heart, L-CPT I contributes approximately 25% to total CPT I activity (in Vmax terms), the value falling during growth of the pups (with concomitant increasing expression of the M isoform) to its adult level of 2-3%. Because the myocardial carnitine content is very low at birth and rises dramatically over the next several weeks, it can be estimated that L-CPT I (Km for carnitine of only 30 microM compared with a value of 500 microM for M-CPT I) is responsible for some 60% of total cardiac fatty acid oxidation in the newborn rat; the value falls to approximately 4% in adult animals. Should these findings have a parallel in humans, they could have important implications for understanding the pathophysiological consequences of inherited L-CPT I deficiency syndromes.lld:pubmed
pubmed-article:7721804pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7721804pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7721804pubmed:languageenglld:pubmed
pubmed-article:7721804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7721804pubmed:citationSubsetIMlld:pubmed
pubmed-article:7721804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7721804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7721804pubmed:statusMEDLINElld:pubmed
pubmed-article:7721804pubmed:monthAprlld:pubmed
pubmed-article:7721804pubmed:issn0021-9258lld:pubmed
pubmed-article:7721804pubmed:authorpubmed-author:McGarryJ DJDlld:pubmed
pubmed-article:7721804pubmed:authorpubmed-author:FosterD WDWlld:pubmed
pubmed-article:7721804pubmed:authorpubmed-author:BrownN FNFlld:pubmed
pubmed-article:7721804pubmed:authorpubmed-author:WeilB JBJlld:pubmed
pubmed-article:7721804pubmed:authorpubmed-author:HustiJ EJElld:pubmed
pubmed-article:7721804pubmed:issnTypePrintlld:pubmed
pubmed-article:7721804pubmed:day14lld:pubmed
pubmed-article:7721804pubmed:volume270lld:pubmed
pubmed-article:7721804pubmed:ownerNLMlld:pubmed
pubmed-article:7721804pubmed:authorsCompleteYlld:pubmed
pubmed-article:7721804pubmed:pagination8952-7lld:pubmed
pubmed-article:7721804pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:meshHeadingpubmed-meshheading:7721804-...lld:pubmed
pubmed-article:7721804pubmed:year1995lld:pubmed
pubmed-article:7721804pubmed:articleTitleMitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart.lld:pubmed
pubmed-article:7721804pubmed:affiliationDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School, Dallas 75235, USA.lld:pubmed
pubmed-article:7721804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7721804pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7721804pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7721804lld:pubmed